What stage of breast cancer includes a tumor greater than 5 cm with fixed axillary nodes?

Study for the Breast Pimping Test. Use flashcards and multiple choice questions, each question is complemented with hints and explanations. Prepare to ace your exam!

Multiple Choice

What stage of breast cancer includes a tumor greater than 5 cm with fixed axillary nodes?

Explanation:
The stage of breast cancer characterized by a tumor greater than 5 cm with fixed axillary nodes is classified as Stage 3A. In this stage, the cancer has advanced beyond the primary tumor, affecting nearby lymph nodes, which are often indicative of a more aggressive disease. Fixed lymph nodes suggest that the cancer has spread to the axillary region, making the treatment approach more complex and necessitating a combination of therapies, such as surgery, radiation, and possibly chemotherapy. Stage 3A specifically reflects the combination of a large tumor size and the involvement of these lymph nodes, emphasizing the need for comprehensive management to address both the primary tumor and the spread to lymphatic structures. The presence of fixed nodes indicates that the cancer is less responsive to therapy, and this classification helps guide treatment decisions and prognostic considerations.

The stage of breast cancer characterized by a tumor greater than 5 cm with fixed axillary nodes is classified as Stage 3A. In this stage, the cancer has advanced beyond the primary tumor, affecting nearby lymph nodes, which are often indicative of a more aggressive disease. Fixed lymph nodes suggest that the cancer has spread to the axillary region, making the treatment approach more complex and necessitating a combination of therapies, such as surgery, radiation, and possibly chemotherapy.

Stage 3A specifically reflects the combination of a large tumor size and the involvement of these lymph nodes, emphasizing the need for comprehensive management to address both the primary tumor and the spread to lymphatic structures. The presence of fixed nodes indicates that the cancer is less responsive to therapy, and this classification helps guide treatment decisions and prognostic considerations.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy